Screener
aTyr Pharma ATYR Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Available-for-sale investments | 41,258 | 67,944 |
| Other receivables | 426 | 873 |
| Prepaid expenses | 518 | 677 |
| Total current assets | 58,362 | 80,237 |
| Restricted cash | 1,495 | 2,235 |
| Property and equipment, net | 4,127 | 4,263 |
| Operating lease, right-of-use assets | 5,353 | 5,524 |
| Financing lease, right-of-use assets | 298 | 596 |
Item 1. Financial Statements
FAQ
- What is aTyr Pharma's total current assets?
- aTyr Pharma (ATYR) reported total current assets of $58.36M in Q2 2026.
- How has aTyr Pharma's total current assets changed year-over-year?
- aTyr Pharma's total current assets decreased by 33.3% year-over-year, from $87.49M to $58.36M.
- What is the long-term trend for aTyr Pharma's total current assets?
- Over 5 years (2020 to 2025), aTyr Pharma's total current assets has grown at a 17.7% compound annual growth rate (CAGR), from $35.53M to $80.24M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about aTyr Pharma's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude